KKR & Company LP is a leading global investment firm that specializes in private equity, energy, infrastructure, real estate, credit, and hedge fund solutions
The company focuses on identifying and investing in high-potential companies and assets across various sectors to drive long-term growth and value creation for their clients and investors. KKR utilizes its extensive industry expertise and strategic resources to enhance operational performance, facilitate transformative growth, and achieve sustainable returns, while also emphasizing responsible investing and maintaining strong relationships with portfolio companies and stakeholders.
Stay tuned for the market movements in the S&P500 index on Friday. Check out the gap up and gap down stocks in the S&P500 index during today's session.
KKR acquired a 65% majority stake in Seiyu from Walmart in 2021 and then bought an additional 20% stake from Rakuten in 2023, taking its total shareholding to 85%. The investments were made from the company’s Asian Fund IV.
Darwinbox, a leading global human resource (“HR”) technology platform, today announced the signing of definitive agreements under which Partners Group, one of the largest firms in the global private markets industry (acting on behalf of its clients), and funds managed by KKR, a leading global investment firm, will co-lead an investment of $140 million in the company, with additional participation from Gravity Holdings. The addition of Partners Group and KKR to an already-solid cap-table underscores Darwinbox’s strong momentum over the recent years. The investment positions Darwinbox well to deepen its technology leadership and accelerate its international expansion plans.
Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top S&P500 gainers and losers in today's session.
KKR, a leading global investment firm, and Seiyu, a nationwide supermarket chain in Japan, today announced the signing of definitive agreements to sell Seiyu (the “Company”) to Trial Holdings, Inc. (TSE stock code 141A; “Trial”), a distribution and retail business operator in Japan that operates a network of stores offering “everyday essentials” in Kyushu. This transaction represents a significant outcome for KKR and follows transformational work that positions Seiyu strongly for continued success.
KKR & Co. Inc. (“KKR”) (NYSEKKR) today announced that it has priced its previously announced offering of $2.25 billion (45,000,000 shares) of its 6.25% Series D Mandatory Convertible Preferred Stock (the “mandatory convertible preferred stock”) at a price to the public and liquidation preference of $50.00 per share. The offering was upsized from the previously announced size of $1.50 billion (30,000,000 shares). The underwriters have a 30-day option to purchase up to an additional $337.50 million (6,750,000 shares) of mandatory convertible preferred stock, solely to cover over-allotments, if any. The offering is expected to close on March 7, 2025, subject to customary closing conditions.
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Tuesday. Discover the gap up and gap down stocks in the S&P500 index.
KKR & Co. Inc. (“KKR”) (NYSEKKR) today announced that it has commenced an offering of $1.5 billion (30,000,000 shares) of its Series D Mandatory Convertible Preferred Stock, par value $0.01 per share (the “mandatory convertible preferred stock”), subject to market and other conditions (the “offering”). KKR expects to grant the underwriters a 30-day option to purchase up to an additional $225 million (4,500,000 shares) of mandatory convertible preferred stock, solely to cover over-allotments, if any.
KKR, a leading global investment firm, and Family Doctor Pty Ltd. (“Family Doctor”), a leading group of general practitioner (“GP”) clinics in Australia, today announced a bespoke financing solution by KKR (through funds managed by KKR) to Family Doctor. KKR’s bespoke financing solution positions the Family Doctor to accelerate its growth and expansion, including through acquisitions.
KKR & CVC Asia V reach definitive agreements to become the largest shareholder in HCG for $400M, with SEBI's Takeover Regulations allowing KKR to acquire up to 77% ownership. Founder will become Non-Executive Chairman as KKR strengthens its focus on India's healthcare sector.
KKR, a leading global investment firm, and Healthcare Global Enterprises (BSE: 539787; NSE: HCG; “HCG”), a leading healthcare organization in India, today announced the signing of definitive agreements with CVC, a leading global private markets manager, under which funds managed by KKR (“KKR”) will become the largest shareholder in HCG and assume sole control of HCG’s operations. Dr. BS Ajaikumar, Founder of HCG, will take on the role of Non-Executive Chairman and be focused on driving clinical, academic and research and development excellence.
KKR has received tenders in excess of 19.25%, the minimum ownership stake required to conduct a squeeze-out. The deal is valued at approximately $4.4 billion.
KKR, a leading global investment firm, today announced that in connection with the two-stage tender offer (the “Tender Offer”) for the common shares and share options of FUJI SOFT INCORPORATED (TSE stock code 9749; “FUJI SOFT” or the “Company”) through FK Co., Ltd. (the “Offeror”), the Offeror, an entity owned by investment funds managed by KKR, received tenders in excess of 19.25%, the minimum ownership stake required to conduct a squeeze-out (53.22% in total), and completed the second stage of its Tender Offer (“Second Tender Offer”) on February 19, 2025.
